Schaller M - Search Results

1

The impact of skin viability on drug metabolism and permeation -- BSA toxicity on primary keratinocytes.

Haberland A, Schreiber S, Maia CS, Rübbelke MK, Schaller M, Korting HC, Kleuser B, Schimke I, Schäfer-Korting M. Haberland A, et al. Among authors: schaller m. Toxicol In Vitro. 2006 Apr;20(3):347-54. doi: 10.1016/j.tiv.2005.08.013. Epub 2005 Sep 21. Toxicol In Vitro. 2006. PMID: 16182510

2

Reconstructed epidermis versus human and animal skin in skin absorption studies.

Schreiber S, Mahmoud A, Vuia A, Rübbelke MK, Schmidt E, Schaller M, Kandárová H, Haberland A, Schäfer UF, Bock U, Korting HC, Liebsch M, Schäfer-Korting M. Schreiber S, et al. Among authors: schaller m. Toxicol In Vitro. 2005 Sep;19(6):813-22. doi: 10.1016/j.tiv.2005.04.004. Toxicol In Vitro. 2005. PMID: 15913948

3

Drug targeting by solid lipid nanoparticles for dermal use.

Santos Maia C, Mehnert W, Schaller M, Korting HC, Gysler A, Haberland A, Schäfer-Korting M. Santos Maia C, et al. Among authors: schaller m. J Drug Target. 2002 Sep;10(6):489-95. doi: 10.1080/1061186021000038364. J Drug Target. 2002. PMID: 12575739

4

RU 58841-myristate--prodrug development for topical treatment of acne and androgenetic alopecia.

Münster U, Nakamura C, Haberland A, Jores K, Mehnert W, Rummel S, Schaller M, Korting HC, Zouboulis ChC, Blume-Peytavi U, Schäfer-Korting M. Münster U, et al. Among authors: schaller m. Pharmazie. 2005 Jan;60(1):8-12. Pharmazie. 2005. PMID: 15700772

5

Tazarotene: therapeutic strategies in the treatment of psoriasis, acne and photoaging.

Roeder A, Schaller M, Schäfer-Korting M, Korting HC. Roeder A, et al. Among authors: schaller m. Skin Pharmacol Physiol. 2004 May-Jun;17(3):111-8. doi: 10.1159/000077236. Skin Pharmacol Physiol. 2004. PMID: 15087589 Review.

6

Safety and efficacy of fluticasone propionate in the topical treatment of skin diseases.

Roeder A, Schaller M, Schäfer-Korting M, Korting HC. Roeder A, et al. Among authors: schaller m. Skin Pharmacol Physiol. 2005 Jan-Feb;18(1):3-11. doi: 10.1159/000081680. Skin Pharmacol Physiol. 2005. PMID: 15608497 Review.

7

[New developments in medical mycology].

Korting HC, Schaller M. Korting HC, et al. Among authors: schaller m. Hautarzt. 2001 Feb;52(2):91-7. doi: 10.1007/s001050051271. Hautarzt. 2001. PMID: 11244898 Review. German.

8

Interaction of cultured human keratinocytes with liposomes encapsulating silver sulphadiazine: proof of the uptake of intact vesicles.

Schaller M, Korting HC, Schmid MH. Schaller M, et al. Br J Dermatol. 1996 Mar;134(3):445-50. Br J Dermatol. 1996. PMID: 8731667

9

Direct evidence for uptake of intact liposomes encapsulating silver sulfadiazine by cultured human keratinocytes based on combined transmission electron microscopy and X-ray microanalysis.

Schaller M, Wurm R, Korting HC. Schaller M, et al. Antimicrob Agents Chemother. 1997 Mar;41(3):717-9. doi: 10.1128/AAC.41.3.717. Antimicrob Agents Chemother. 1997. PMID: 9056023 Free PMC article.

10

Light and electron microscopic findings in human epidermis reconstructed in vitro upon topical application of liposomal tretinoin.

Schaller M, Steinle R, Korting HC. Schaller M, et al. Acta Derm Venereol. 1997 Mar;77(2):122-6. doi: 10.2340/0001555577122126. Acta Derm Venereol. 1997. PMID: 9111822 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

880 results

Search Page

Filters